G2 Awards Recognize Diagnostics Leaders and Innovators

Amidst three days of networking, workshops, panel discussions and presentations focused on the challenges and opportunities facing laboratories and pathologists, two leaders in diagnostics were honored for their commitment to the laboratory industry, public service and innovation in diagnostics.

Public Service Distinguished Leadership Award Sponsored by Kellison & Company

Mark Ziebarth, G2 Intelligence president and publisher; Gregory S. Henderson, M.D., Ph.D, President of BioReference Laboratories; and Scott Liff, chief executive officer of Kellison & Company

Gregory S. Henderson, M.D., Ph.D., was awarded the 2016 G2 Laboratory Public Service Distinguished Leadership Award, sponsored by Kellison & Company, a revenue cycle management solutions company. Kellison’s Chief Executive Officer Scott Liff presented the award at G2’s 34th Annual Lab institute Conference at the Hyatt Regency Capitol Hill, Washington, D.C. on Thursday, Oct. 27, 2016.

For almost a decade, Kellison has sponsored this annual award, presented to a diagnostic laboratory industry executive exemplifying the traits of leadership, excellence, and service to the industry. The award recognizes contributions to enhancing patient care and the laboratory profession through business management, research, public policy or service and innovation.

Dr. Henderson was named President of BioReference Laboratories, a division of OPKO Health, Inc. in March 2016. He has served as a leader in pathology and laboratory medicine as a pathologist, executive and innovator. He has guided business growth and operations of one of the largest laboratory outreach programs in the United States, served on a team charged with rebuilding healthcare infrastructure in New Orleans after Hurricane Katrina, co-developed the first cloud based anatomic pathology information system, and founded a company that leverages cloud technology solutions to provide digital pathology consultations that afford access to quality diagnostics in the developed and developing world.

Lab Innovation Award Sponsored by Halfpenny

Mark Ziebarth, G2 Intelligence president and publisher; Analyte Health Chief Executive Officer Dr. Frank Cockerill; and Jack Redding, senior vice president, sales and marketing, for Halfpenny Technologies

Dr. Frank Cockerill, Chief Executive Officer of Analyte Health, received G2 Intelligence’s Lab Innovation Award, designed to recognize innovation in the field of diagnostics. The award, sponsored by Halfpenny Technologies Inc., was presented by Jack Redding, senior vice president, sales and marketing, for Halfpenny, on Friday, Oct. 28 at Lab Institute in Washington, D.C. Cockerill was recognized for his leadership of Analyte Health in innovating patient access to diagnostic testing. As CEO, Cockerill is leading Analyte Health in pioneering online diagnostic services aimed directly to consumers—including education, diagnostic testing, personalized results and recommendations about next steps. Similarly, award sponsor Halfpenny also strives to improve access to diagnostic test results with its interoperability solutions that enable clinical data exchange through secure, scalable, cloud-based, vendor neutral clinical data exchange platforms.

Cockerill previously led the Department of Laboratory Medicine and Pathology at Mayo Clinic and was Chief Executive Officer of Mayo Medical Laboratories, a global reference laboratory operating within Mayo Clinic. He was also the Ann and Leo Markin Professor of Microbiology and Medicine at the Mayo Clinic College of Medicine, having extensive experience and expertise in infectious diseases and antimicrobial resistance.